The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant.

CONCLUSION: The adoption of the GHSG risk model at the time of recurrence/progression is a useful prognostic tool to select patients with Hodgkin lymphoma for consolidative involved-field radiotherapy after autologous stem cell transplantation.
PMID: 31178272 [PubMed - as supplied by publisher]

Source: Cancer Radiotherapie - June 5, 2019 Category: Cancer & Oncology Authors: Furlan C, Matrone F, Rupolo M, Ciancia R, Zanet E, Montante B, Palazzari E, Navarria F, Trovo M, Bulian P, Spina M, Coassin E, Mascarin M, De Paoli A, Franchin G, Michieli M Tags: Cancer Radiother Source Type: research